BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 23, 1994
View Archived Issues
XOMA DISCONTINUES DEVELOPMENT OF CD5 PLUS
Read More
GLYCOMED'S PHASE II/III RESULTS OF GALARDIN ARE POSITIVE
Read More
AMGEN'S NEUPOGEN APPROVED FOR SEVERE CHRONIC NEUTROPENIA
Read More
SCHERER `DEMANDS' ACCESS TO PROCYTE'S SHAREHOLDER LIST
Read More
PTO TELLS ITS EXAMINERS TO ACCEPT `CREDIBLE' CLAIMS
Read More
PHARMACOPEIA SIGNS POTENTIAL $75M DEAL WITH SCHERING-PLOUGH
Read More
CENTOCOR GIVES BIOTECH A BOOST WITH FDA APPROVAL OF REOPRO
Read More